These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 32030938)

  • 1. [How to explore… a cervical dystonia].
    Depierreux F; Jedidi H; Hardy PY; Parmentier E; Garraux G
    Rev Med Liege; 2020 Feb; 75(2):121-124. PubMed ID: 32030938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin type A therapy in a patient with cervical dystonia and amyotrophic lateral sclerosis.
    Singer C; Papapetropaulos S; Ayyar DR; Verma A
    Mov Disord; 2007 Jan; 22(2):289. PubMed ID: 17094101
    [No Abstract]   [Full Text] [Related]  

  • 3. Botulinum toxin treatment of axial and cervical dystonia.
    Benecke R; Dressler D
    Disabil Rehabil; 2007 Dec; 29(23):1769-77. PubMed ID: 18033602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Headache attributed to craniocervical dystonia: A prospective cohort study.
    Eugenio Ramalho Bezerra M; Sampaio Rocha-Filho PA
    Eur J Pain; 2020 Sep; 24(8):1484-1494. PubMed ID: 32422691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical profile of botulinum toxin A in patients with chronic headaches and cervical dystonia: a prospective, open-label, longitudinal study conducted in a naturalistic clinical practice setting.
    Dowson AJ; Kilminster SG; Salt R
    Drugs R D; 2008; 9(3):147-58. PubMed ID: 18457467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin therapy for cervical dystonia.
    Jankovic J
    Neurotox Res; 2006 Apr; 9(2-3):145-8. PubMed ID: 16785112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dystonia in a patient with ring chromosome 21.
    Hou CE; Schlaggar BL; Racette BA
    Mov Disord; 2003 Dec; 18(12):1547-9. PubMed ID: 14673898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: Randomized, double-blind, noninferiority trial.
    Pappert EJ; Germanson T;
    Mov Disord; 2008 Mar; 23(4):510-7. PubMed ID: 18098274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pilot study of botulinum toxin A for headache in cervical dystonia.
    Ondo WG; Gollomp S; Galvez-Jimenez N
    Headache; 2005 Sep; 45(8):1073-7. PubMed ID: 16109123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin for cervical dystonia.
    Med Lett Drugs Ther; 2001 Jul; 43(1109):63-4. PubMed ID: 11468603
    [No Abstract]   [Full Text] [Related]  

  • 11. Quality of life in long-term botulinum toxin treatment of cervical dystonia: Results of a cross sectional study.
    Moll M; Rosenthal D; Hefter H
    Parkinsonism Relat Disord; 2018 Dec; 57():63-67. PubMed ID: 30150129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervical dystonia presenting as a phenocopy in an Irish SCA2 family.
    Walsh R; O'Dwyer JP; O'Riordan S; Bradley D; Moroney J; Hutchinson M
    Mov Disord; 2009 Feb; 24(3):466-7. PubMed ID: 19086087
    [No Abstract]   [Full Text] [Related]  

  • 13. The impact of blepharospasm and cervical dystonia on health-related quality of life and depression.
    Müller J; Kemmler G; Wissel J; Schneider A; Voller B; Grossmann J; Diez J; Homann N; Wenning GK; Schnider P; Poewe W;
    J Neurol; 2002 Jul; 249(7):842-6. PubMed ID: 12140667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bilateral Lower Sternocleidomastoid Botulinum Toxin Injections to Address Refractory Anterocollis.
    Peng-Chen Z; Thompson A; Rodriguez RL
    Neurologist; 2016 Mar; 21(2):30-1. PubMed ID: 26926853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Headache in cranial and cervical dystonia.
    Barbanti P; Fabbrini G; Pauletti C; Defazio G; Cruccu G; Berardelli A
    Neurology; 2005 Apr; 64(7):1308-9. PubMed ID: 15824376
    [No Abstract]   [Full Text] [Related]  

  • 16. Anatomy and cervical dystonia : "Dysfunction follows form".
    Tatu L; Jost WH
    J Neural Transm (Vienna); 2017 Feb; 124(2):237-243. PubMed ID: 27624726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up of cervical dystonia patients treated with botulinum toxin A.
    Haussermann P; Marczoch S; Klinger C; Landgrebe M; Conrad B; Ceballos-Baumann A
    Mov Disord; 2004 Mar; 19(3):303-8. PubMed ID: 15022184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Spasmodic torticollis: experience of 5 years with botulinum toxin treatment].
    Domzał TM
    Neurol Neurochir Pol; 1999; 33(2):351-7. PubMed ID: 10463249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reply: Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: randomized, double-blind, noninferiority trial.
    Mueller J
    Mov Disord; 2009 May; 24(7):1098-9; author reply 1100. PubMed ID: 18942082
    [No Abstract]   [Full Text] [Related]  

  • 20. Factors affecting the health-related quality of life of patients with cervical dystonia and the impact of botulinum toxin type A injections.
    Slawek J; Friedman A; Potulska A; Krystkowiak P; Gervais C; Banach M; Ochudlo S; Budrewicz S; Reclawowicz D; Rynkowski M; Opala G
    Funct Neurol; 2007; 22(2):95-100. PubMed ID: 17637212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.